Logo image of GLRE

GREENLIGHT CAPITAL RE LTD-A (GLRE) Stock Fundamental Analysis

USA - NASDAQ:GLRE - KYG4095J1094 - Common Stock

12.55 USD
0 (0%)
Last: 9/16/2025, 8:27:05 PM
12.55 USD
0 (0%)
After Hours: 9/16/2025, 8:27:05 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GLRE. GLRE was compared to 146 industry peers in the Insurance industry. The financial health of GLRE is average, but there are quite some concerns on its profitability. GLRE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year GLRE was profitable.
In the past year GLRE had a positive cash flow from operations.
GLRE had positive earnings in each of the past 5 years.
In multiple years GLRE reported negative operating cash flow during the last 5 years.
GLRE Yearly Net Income VS EBIT VS OCF VS FCFGLRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

GLRE's Return On Assets of 1.73% is in line compared to the rest of the industry. GLRE outperforms 49.32% of its industry peers.
With a Return On Equity value of 5.69%, GLRE is not doing good in the industry: 69.18% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 1.73%
ROE 5.69%
ROIC N/A
ROA(3y)2.92%
ROA(5y)2.05%
ROE(3y)8.8%
ROE(5y)6.18%
ROIC(3y)N/A
ROIC(5y)N/A
GLRE Yearly ROA, ROE, ROICGLRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 5.84%, GLRE is in line with its industry, outperforming 41.10% of the companies in the same industry.
GLRE's Profit Margin has improved in the last couple of years.
GLRE's Operating Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for GLRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 5.84%
GM N/A
OM growth 3Y-37.65%
OM growth 5YN/A
PM growth 3Y30.1%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLRE Yearly Profit, Operating, Gross MarginsGLRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GLRE has been reduced compared to 1 year ago.
The number of shares outstanding for GLRE has been reduced compared to 5 years ago.
The debt/assets ratio for GLRE has been reduced compared to a year ago.
GLRE Yearly Shares OutstandingGLRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GLRE Yearly Total Debt VS Total AssetsGLRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of GLRE is 0.40, which is an excellent value as it means it would take GLRE, only 0.40 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.40, GLRE belongs to the best of the industry, outperforming 84.25% of the companies in the same industry.
GLRE has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.09, GLRE is in the better half of the industry, outperforming 76.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.4
Altman-Z N/A
ROIC/WACCN/A
WACC8.34%
GLRE Yearly LT Debt VS Equity VS FCFGLRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GLRE Yearly Current Assets VS Current LiabilitesGLRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GLRE have decreased strongly by -43.68% in the last year.
Measured over the past years, GLRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.26% on average per year.
GLRE shows a small growth in Revenue. In the last year, the Revenue has grown by 0.16%.
The Revenue has been growing slightly by 4.45% on average over the past years.
EPS 1Y (TTM)-43.68%
EPS 3Y34.26%
EPS 5YN/A
EPS Q2Q%-95.65%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y3.53%
Revenue growth 5Y4.45%
Sales Q2Q%-16.37%

3.2 Future

Based on estimates for the next years, GLRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.14% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.59%
EPS Next 2Y16.14%
EPS Next 3Y8.14%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLRE Yearly Revenue VS EstimatesGLRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
GLRE Yearly EPS VS EstimatesGLRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6 -8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.73, the valuation of GLRE can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of GLRE is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.20, GLRE is valued rather cheaply.
The Price/Forward Earnings ratio is 7.69, which indicates a rather cheap valuation of GLRE.
Based on the Price/Forward Earnings ratio, GLRE is valued a bit cheaper than the industry average as 71.23% of the companies are valued more expensively.
GLRE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.73
Fwd PE 7.69
GLRE Price Earnings VS Forward Price EarningsGLRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, GLRE is valued cheaply inside the industry as 83.56% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.9
EV/EBITDA N/A
GLRE Per share dataGLRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.22
PEG (5Y)N/A
EPS Next 2Y16.14%
EPS Next 3Y8.14%

More info and screens

0

5. Dividend

5.1 Amount

GLRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (9/16/2025, 8:27:05 PM)

After market: 12.55 0 (0%)

12.55

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03
Inst Owners48.97%
Inst Owner Change3.22%
Ins Owners24.31%
Ins Owner Change0.01%
Market Cap429.21M
Analysts43.33
Price TargetN/A
Short Float %4.68%
Short Ratio9.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)85.71%
Min EPS beat(2)68.63%
Max EPS beat(2)102.8%
EPS beat(4)3
Avg EPS beat(4)-911.7%
Min EPS beat(4)-3870.59%
Max EPS beat(4)102.8%
EPS beat(8)5
Avg EPS beat(8)-427.11%
EPS beat(12)8
Avg EPS beat(12)-357.76%
EPS beat(16)9
Avg EPS beat(16)-278.54%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-18.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.73
Fwd PE 7.69
P/S 0.66
P/FCF 2.9
P/OCF 2.87
P/B 0.65
P/tB 0.65
EV/EBITDA N/A
EPS(TTM)1.07
EY8.53%
EPS(NY)1.63
Fwd EY13%
FCF(TTM)4.33
FCFY34.54%
OCF(TTM)4.37
OCFY34.79%
SpS18.91
BVpS19.4
TBVpS19.4
PEG (NY)1.22
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 5.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.84%
GM N/A
FCFM 22.92%
ROA(3y)2.92%
ROA(5y)2.05%
ROE(3y)8.8%
ROE(5y)6.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-37.65%
OM growth 5YN/A
PM growth 3Y30.1%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.4
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 392.46%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.68%
EPS 3Y34.26%
EPS 5YN/A
EPS Q2Q%-95.65%
EPS Next Y9.59%
EPS Next 2Y16.14%
EPS Next 3Y8.14%
EPS Next 5YN/A
Revenue 1Y (TTM)0.16%
Revenue growth 3Y3.53%
Revenue growth 5Y4.45%
Sales Q2Q%-16.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124.4%
EBIT growth 3Y-35.45%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y960.92%
FCF growth 3YN/A
FCF growth 5Y132.37%
OCF growth 1Y967.15%
OCF growth 3YN/A
OCF growth 5Y132.82%